Compare Adobe Systems Inc (ADBE) vs GeneDx Holdings Corp (WGS) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
Adobe Systems Inc vs GeneDx Holdings Corp — how do they compare? Adobe Systems Inc trades at $219.39 (market cap $88.06B), while GeneDx Holdings Corp trades at $65 (market cap $1.94B). The key difference: Adobe Systems Inc is far larger — about 45.4× GeneDx Holdings Corp's market cap. Which is the better fit depends on your goals.
| ADBE | WGS | |
|---|---|---|
Market Cap | $88.06B | $1.94B |
Volume | 5,187,646 | — |
Sector | Technology | Technology |
52-Week High | $382.24 | $167.51 |
52-Week Low | $193.41 | $34.51 |
Enterprise Value | $89.50B | $1.94B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Adobe (ADBE) trades at $221.54, up 1.59% today, with a bullish technical signal despite near-term overbought RSI conditions. The company reported strong Q1 2026 earnings, beating EPS estimates with $5.96 vs. $5.82 expected. Revenue grew to $23.77B in 2025, with net income margin expanding to 29.99%. However, negative net cash flow of -$2.18B in 2025 and rising debt-to-asset ratio to 18.61% highlight financial pressures.
Outlook remains positive with analyst consensus price target of $246.75 (11.4% upside), but AI competition and CEO transition risks weigh on sentiment. Institutional buying continues, yet legal scrutiny and sector volatility pose near-term challenges. Valuation metrics like P/E of 12.67 and EV/EBITDA of 8.83 suggest relative undervaluation versus peers if growth sustains.
GeneDx Holdings Corp. (WGS) trades at $68.89, up 2.04% today, with a bullish technical signal from moving averages and a consensus analyst price target of $75.40. Despite recent earnings beats in Q3 and Q4 2025, the company reported a net loss of -$21.02M in 2025, with profitability metrics like ROE at -30.42% reflecting operational challenges. The stock faces headwinds from a securities class action lawsuit alleging fraud, as noted in multiple legal alerts from July 2026.
The outlook is mixed: strong analyst buy ratings (90.91%) suggest upside potential, but negative margins and legal risks pose significant threats. Investors should weigh the high valuation multiples, such as EV/EBITDA of 161.17, against growth prospects in the genomics sector, with cash flow trends showing volatility into 2026.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Adobe Systems Inc
Adobe Inc. develops, markets, and supports computer software products and technologies. The Company's products allow users to express and use information across all print and electronic media. Adobe offers a line of application software products, type products, and content for creating, distributing, and managing information.
Read more on ADBE →About GeneDx Holdings Corp
GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.
Read more on WGS →
